Faculty/Authors
MEAGAN CHAMBERS, MD, MS, MSC
Department of Pathology and Laboratory Medicine
University of Washington
Seattle, Washington 

CME Credit: 2.0
Estimated Completion Time: 2 hours
Format: Online Educational Activity and Post Exam

Physician Competencies: Patient Care, Medical Knowledge

Eligibility for CME credit: Max three attempts. You will have a maximum of three attempts to meet the following criteria:

• Module ≥80% = CME credit
• Module <80% = No CME credit, after a maximum of three attempts

Default Credit Type: None (You must meet the eligibility requirements in order to obtain CME credit.)

Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

1. Review the Technical Considerations.
2. Click Go to Course to view an overview of the modules in this course.
3. Click Access to begin the course.
4. Choose the CME Activity to earn CME credit.

To claim CME credit for the exercise, do the following:

1. Review the Educational Activity.
2. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
3. Submit the course Evaluation.
4. Enter the maximum number of credits offered and click Claim CME to register credit.

Faculty Disclosures

Technical Considerations

Release Date: 02/25/2022
Review Date:
Expiration Date: 12/31/2024

• describe the acute pulmonary findings of fatal COVID-19;  

• critically evaluate the evidence for and against coagulopathy as a unique finding in COVID-19 

• contrast the proposed primary effects of COVID-19 in the heart and kidney with the postmortem findings attributed to preexisting conditions; and  

• discuss the limitations in the literature with regard to pathologic findings of COVID-19.